This inventor holds 1 USPTO granted patent. Top assignee: Imtm Gmbh. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Marco Arndt: Innovator in Enzyme Inhibition for Therapeutic Applications
Introduction
Marco Arndt is a notable inventor based in Merseburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme inhibitors. His innovative work focuses on therapeutic applications for autoimmune diseases and chronic inflammatory conditions.
Latest Patents
Marco Arndt holds a patent for "Combinations of enzyme inhibitor-containing preparations and the use thereof." This invention outlines a process that inhibits DNA synthesis and the proliferation of mononuclear cells and T cells through the combined inhibition of specific enzyme activities. The patent emphasizes that the simultaneous application of multiple enzyme inhibitors results in a more effective and long-lasting therapeutic effect compared to single inhibitors.
Career Highlights
Arndt's career is marked by his dedication to advancing medical therapies through innovative research. He is associated with Imtm GmbH, where he collaborates with other experts in the field. His work has the potential to significantly impact the treatment of autoimmune diseases and improve patient outcomes.
Collaborations
Marco Arndt has worked alongside notable colleagues such as Uwe Lendeckel and Siegfried Ansorge. Their collaborative efforts have contributed to the development of effective therapeutic strategies in the realm of enzyme inhibition.
Conclusion
Marco Arndt's contributions to enzyme inhibition represent a significant advancement in therapeutic applications for various diseases. His innovative approach and dedication to research continue to pave the way for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
